MARKET

SIGA

SIGA

Siga Technologie
NASDAQ
5.91
+0.07
+1.20%
After Hours: 5.98 +0.07 +1.18% 17:47 05/23 EDT
OPEN
5.74
PREV CLOSE
5.84
HIGH
6.02
LOW
5.71
VOLUME
479.59K
TURNOVER
--
52 WEEK HIGH
11.62
52 WEEK LOW
4.482
MARKET CAP
422.22M
P/E (TTM)
8.78
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SIGA last week (0512-0516)?
Weekly Report · 4d ago
Weekly Report: what happened at SIGA last week (0505-0509)?
Weekly Report · 05/12 11:53
SIGA Technologies’ Earnings Call Highlights Growth and Stability
TipRanks · 05/10 00:38
SIGA Technologies Q1 EPS $(0.01) Down From $0.14 YoY, Sales $7.04M Down From $25.43M YoY
Benzinga · 05/08 20:32
SIGA Technologies GAAP EPS of -$0.01, revenue of $7M
Seeking Alpha · 05/08 20:22
Press Release: SIGA Reports Financial Results for Three Months Ended March 31, 2025
Dow Jones · 05/08 20:05
Lobbying Update: $50,000 of SIGA TECHNOLOGIES lobbying was just disclosed
NASDAQ · 05/05 20:02
Weekly Report: what happened at SIGA last week (0428-0502)?
Weekly Report · 05/05 11:57
More
About SIGA
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company. The Company is focused on the development of medicines to treat and prevent infectious diseases. Its flagship product, TPOXX (tecovirimat), is an antiviral medicine approved in the United States and Canada for the treatment of smallpox and authorized in Europe, the United Kingdom, and Japan for the treatment of smallpox, monkeypox (mpox), cowpox, and vaccinia complications. TPOXX specifically inhibits the activity of a protein called VP37, found on the surface of all orthopoxviruses. This prevents the virus from leaving infected cells, slowing the spread of the infection and limiting it to a point where the immune system can clear the virus. The European Medicines Agency and United Kingdom approvals include labeling for oral tecovirimat indicating its use for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications following vaccination against smallpox.

Webull offers SIGA Technologies Inc stock information, including NASDAQ: SIGA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SIGA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SIGA stock methods without spending real money on the virtual paper trading platform.